Pierre, Fabre Pierre Fabre Laboratories recibe un dictamen positivo por parte del CHPM por el BRAFTOVI® en combinación con MEKTOVI® Published on 08/07/2025 at 18:08 | prnewswire.co.uk PIERRE FABRE LABORATORIES Canada France Germany Spain United States of America United Kingdom View original content:https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-recibe-un-dictamen-positivo-por-parte-del-chpm--comite-de-medicamentos-para-uso-humano-por-el-braftovi-encorafenib-en-combinacion-con-mektovi-binimetinib-302207725.html en | boerse | 67931021 |
